Inder Kaul, MD
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
3
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Sanjeev Pathak, MD
Alkermes, Inc.
Shared therapeutic areas:
Ginger Nicol, MD
Washington University School of Medicine
Shared therapeutic areas:
Benedicto Crespo-Facorro, Professor
University Hospital Marqués de Valdecilla, IDIVAL, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain. CIBERSAM Centro Investigación Biomédica en Red Salud Mental, Madrid, Spain
Shared therapeutic areas:
Scott W Woods, MD
Yale University
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Nobuhito Sanada
Otsuka Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Eva Kohegyi, MD
Otsuka Pharmaceutical Development & Commercialization, Inc.
Shared therapeutic areas:
BioXcel MM, MD
BioXcel Therapeutics
Shared therapeutic areas:
William Honer, MD
University of British Columbia
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3)
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)
All 3 trials loaded